Liwei Ren

769 total citations
30 papers, 574 citations indexed

About

Liwei Ren is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Liwei Ren has authored 30 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Surgery and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Liwei Ren's work include Renin-Angiotensin System Studies (9 papers), Hormonal Regulation and Hypertension (6 papers) and Pancreatic function and diabetes (5 papers). Liwei Ren is often cited by papers focused on Renin-Angiotensin System Studies (9 papers), Hormonal Regulation and Hypertension (6 papers) and Pancreatic function and diabetes (5 papers). Liwei Ren collaborates with scholars based in China, Netherlands and United States. Liwei Ren's co-authors include A.H. Jan Danser, Estrellita Uijl, Ping Zhan, Zhiwen Yu, Xifeng Lu, Katrina M. Mirabito Colafella, Ingrid M. Garrelds, Richard van Veghel, Don Foster and Qinghua Wang and has published in prestigious journals such as Circulation Research, Biochemical and Biophysical Research Communications and Hypertension.

In The Last Decade

Liwei Ren

28 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liwei Ren China 14 282 196 168 113 84 30 574
Luuk te Riet Netherlands 9 280 1.0× 372 1.9× 234 1.4× 96 0.8× 99 1.2× 10 855
Yusuf Olğar Türkiye 15 354 1.3× 236 1.2× 157 0.9× 117 1.0× 116 1.4× 41 717
Caterina Constantinou Greece 16 287 1.0× 72 0.4× 170 1.0× 103 0.9× 139 1.7× 32 636
Malak Abbas France 15 262 0.9× 175 0.9× 169 1.0× 111 1.0× 131 1.6× 34 755
Teresa Sousa Portugal 16 136 0.5× 244 1.2× 84 0.5× 97 0.9× 139 1.7× 46 665
Aya Shiraki Japan 8 168 0.6× 83 0.4× 215 1.3× 99 0.9× 84 1.0× 16 513
Gongchang Guan China 15 233 0.8× 170 0.9× 70 0.4× 66 0.6× 86 1.0× 38 627
Marjut Louhelainen Finland 15 307 1.1× 203 1.0× 57 0.3× 61 0.5× 135 1.6× 20 698
Jun Song China 14 406 1.4× 57 0.3× 277 1.6× 134 1.2× 142 1.7× 31 832

Countries citing papers authored by Liwei Ren

Since Specialization
Citations

This map shows the geographic impact of Liwei Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Ren more than expected).

Fields of papers citing papers by Liwei Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liwei Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Ren. The network helps show where Liwei Ren may publish in the future.

Co-authorship network of co-authors of Liwei Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Liwei Ren. A scholar is included among the top collaborators of Liwei Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liwei Ren. Liwei Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Liwei & A.H. Jan Danser. (2025). Small Interfering RNA Therapy for the Management and Prevention of Hypertension. Current Hypertension Reports. 27(1). 5–5. 1 indexed citations
3.
Wang, Na, Liwei Ren, & A.H. Jan Danser. (2024). Vacuolar H+‐ATPase in Diabetes, Hypertension, and Atherosclerosis. Microcirculation. 31(5). e12855–e12855. 7 indexed citations
4.
Uijl, Estrellita, Dien Ye, Liwei Ren, et al.. (2022). Conventional Vasopressor and Vasopressor‐Sparing Strategies to Counteract the Blood Pressure–Lowering Effect of Small Interfering RNA Targeting Angiotensinogen. Journal of the American Heart Association. 11(15). e026426–e026426. 25 indexed citations
5.
Bovée, Dominique M., Liwei Ren, Estrellita Uijl, et al.. (2021). Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney Disease. Hypertension. 77(5). 1600–1612. 22 indexed citations
6.
Ye, Dien, Xiaofei Yang, Liwei Ren, et al.. (2021). (Pro)renin Receptor Inhibition Reduces Plasma Cholesterol and Triglycerides but Does Not Attenuate Atherosclerosis in Atherosclerotic Mice. Frontiers in Cardiovascular Medicine. 8. 725203–725203. 5 indexed citations
7.
Uijl, Estrellita, Katrina M. Mirabito Colafella, Yuan Sun, et al.. (2019). Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver Angiotensinogen. Hypertension. 73(6). 1249–1257. 88 indexed citations
8.
Ren, Liwei, Xifeng Lu, & A.H. Jan Danser. (2019). Revisiting the Brain Renin-Angiotensin System—Focus on Novel Therapies. Current Hypertension Reports. 21(4). 28–28. 42 indexed citations
9.
Ren, Liwei, Wenjuan Liu, Liqian Wang, et al.. (2019). Novel GLP-1 Analog Supaglutide Stimulates Insulin Secretion in Mouse and Human Islet Beta-Cells and Improves Glucose Homeostasis in Diabetic Mice. Frontiers in Physiology. 10. 930–930. 17 indexed citations
10.
Ren, Liwei, Ping Zhan, Qi Wang, et al.. (2019). Curcumin upregulates the Nrf2 system by repressing inflammatory signaling-mediated Keap1 expression in insulin-resistant conditions. Biochemical and Biophysical Research Communications. 514(3). 691–698. 48 indexed citations
11.
Ren, Liwei, Katrina M. Mirabito Colafella, Dominique M. Bovée, Estrellita Uijl, & A.H. Jan Danser. (2019). Targeting angiotensinogen with RNA-based therapeutics. Current Opinion in Nephrology & Hypertension. 29(2). 180–189. 22 indexed citations
12.
Wang, Qinghua, Liwei Ren, Yun Wan, & Gérald J. Prud’homme. (2019). GABAergic regulation of pancreatic islet cells: Physiology and antidiabetic effects. Journal of Cellular Physiology. 234(9). 14432–14444. 43 indexed citations
13.
Li, Junfeng, Zhihong Wang, Liwei Ren, et al.. (2018). Antagonistic interaction between Nodal and insulin modulates pancreatic β-cell proliferation and survival. Cell Communication and Signaling. 16(1). 79–79. 7 indexed citations
14.
Yang, Xiaofei, et al.. (2017). Immunogenicity of insulin-producing cells derived from human umbilical cord mesenchymal stem cells. Experimental and Therapeutic Medicine. 13(4). 1456–1464. 26 indexed citations
15.
Zhou, Ziyu, et al.. (2016). Metformin exerts glucose-lowering action in high-fat fed mice via attenuating endotoxemia and enhancing insulin signaling. Acta Pharmacologica Sinica. 37(8). 1063–1075. 75 indexed citations
16.
Zhou, Ziyu, et al.. (2015). Effect of short-term acumagnetotherapy on diabetic kidney disease in patients with type II diabetes and study on the molecular mechanism. World Journal of Acupuncture - Moxibustion. 25(3). 1–10. 2 indexed citations
17.
Hui, Pei, Haiyan Wu, Liwei Ren, et al.. (2013). Relationship between iNOS expression and apoptosis in cerebral tissue, and the effect of Sini injection in endotoxin shock rats. Journal of Traditional Chinese Medicine. 33(4). 486–491. 4 indexed citations
18.
Zhang, Yuzhong, Haiyan Wu, Liwei Ren, et al.. (2010). Study on Modified Shengmai Yin Injection for Prevention and Treatment of Brain Impairment in Endotoxin Shock Rats. Journal of Traditional Chinese Medicine. 30(4). 272–277. 5 indexed citations
19.
Hui, Pei, et al.. (2009). Effects of sini decoction on TNF-α, SOD in cerebral tissue of rats with endotoxic shock.. Zhonghua zhongyiyao zazhi. 24(6). 728–730. 1 indexed citations
20.
Zhang, Ying, Yufeng Jiang, Zhiqin Liu, et al.. (2007). [Effect of salvianolic acid B on brain energy metabolism and hydrocephalus of cerebral ischemia in mice at different time].. PubMed. 42(12). 1250–3. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026